ABSTRACT
Introduction The impact of workflow changes and total laboratory automation (TLA) on microbiology culture processing time was evaluated in an academic-affiliated regional hospital.
Materials and Methods A retrospective analysis of microbiological data in a research database was performed to compare turnaround time (TAT) for organism identification (ID) before and after implementation of TLA (2013 versus 2016, respectively). TAT was compared using the χ2 test for categorical variables and log-transformed t-test for continuous variables.
Results A total of 9,351 predefined common and clinically important positive mono-bacterial culture results were included in the analysis. Shorter TAT (hours) in 2016 compared to 2013 (p<0.0001) for positive result pathogen ID were observed in specimen types including blood (51.2 vs. 70.6), urine (40.7 vs. 47.1), wound (39.6 vs. 60.2), respiratory (47.7 vs. 67), and all specimen types combined (43.3 vs. 56.8). Although shorter TATs were not observed from all specimen categories for negative result pathogen ID, TAT for all specimen types combined was shorter (p≤0.001) in 2016 compared to 2013 (94 vs. 101).
Conclusions Total laboratory automation and workflow changes—including process standardization—facilitate shorter organism ID TAT across specimen sources.
- Laboratory automation
- Microbiology
- Clinical laboratory
- Laboratory workflow
- Turnaround time
Competing Interest Statement
This study was approved by the Quality Improvement Review Board of the study site. The researchers at Texas Tech University Health Sciences Center, University Medical Center, Lubbock, TX, and Becton, Dickinson and Co. Franklin Lakes, NJ conducted the analysis as their normal working responsibilities. YPT, LV, SK, DS, MW, CA are current or former employees of Becton, Dickinson, and Company, the manufacturer of the BD Kiestra TLA system implemented by the study site. AE, CGO, SS, JN, and FL do not have any other disclosures. All authors provided final approval of the manuscript and agree to be accountable for the accuracy and integrity of this work.
Clinical Trial
This was not a clinical trial.
Funding Statement
This work was supported in part by Becton, Dickinson and Company.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Texas Tech University Health Sciences Center - Institutional Quality Improvement Review Approval number 17005; expiration date: 05/15/2021.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Source of support: This work was supported in part by Becton, Dickinson and Company.
Abstract (original), lines 12-13: "were observed in specimen types including blood (40.7 vs. 47.1), urine (30 vs 44), wound (39.6 vs. 60.2), respiratory (47.7 vs. 67), and all specimen types, combined (43.3 vs. 56.8). Although shorter TAT were not observed from all" Changed to: "were observed in specimen types including blood (51.2 vs. 70.6), urine (40.7 vs. 47.1), wound (39.6 vs. 60.2), respiratory (47.7 vs. 67), and all specimen types combined (43.3 vs. 56.8). Although shorter TATs were not observed from all
Data Availability
Data requests should be directed to David Sellers at David.Sellers[at]bd.com
Abbreviations
- TLA
- total laboratory automation;
- SOP
- standard operating procedure;
- MALDI-TOF
- matrix-assisted laser desorption ionization time-of-flight mass spectrometry;
- TAT
- turnaround time;
- ID
- identification;
- ASM
- American Society of Microbiology;
- CLSI
- Clinical Laboratory Standards Institute;
- MT
- medical technologist
